{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:09:31Z","timestamp":1781899771124,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.mito.2019.11.001","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T11:54:14Z","timestamp":1574164454000},"page":"145-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Cerebrospinal fluid ATP as a potential biomarker in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS)"],"prefix":"10.1016","volume":"50","author":[{"given":"Takamasa","family":"Nukui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Lan","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyo","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakatsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mito.2019.11.001_b0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-genom-091416-035426","article-title":"Recent advances in mitochondrial disease","volume":"18","author":"Craven","year":"2017","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.mito.2019.11.001_b0010","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1373\/clinchem.2006.081166","article-title":"Diagnostic accuracy of blood lactate-to-pyruvate molar ratio in the differential diagnosis of congenital lactic acidosis","volume":"53","author":"Debray","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mito.2019.11.001_b0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","article-title":"MELAS syndrome: clinical manifestations, pathogenesis, and treatment options","volume":"116","author":"El-Hattab","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2019.11.001_b0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/WNL.42.3.545","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation","volume":"42","author":"Goto","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2019.11.001_b0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/088307389400900102","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts","volume":"9","author":"Hirano","year":"1994","journal-title":"J. Child Neurol."},{"issue":"22","key":"10.1016\/j.mito.2019.11.001_b0030","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1212\/WNL.0b013e31823a0c7f","article-title":"Natural history of MELAS associated with mitochondrial DNA m.3243A > G genotypes","volume":"77","author":"Kaufmann","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2019.11.001_b0035","first-page":"480","article-title":"Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA (Leu (UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes","volume":"12","author":"King","year":"1992","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mito.2019.11.001_b0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejpn.2010.10.001","article-title":"Elevated CSF-lactate is a reliable marker of mitochondrial disorders in children even after brief seizures","volume":"15","author":"Mager","year":"2011","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.mito.2019.11.001_b0045","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/bio.3246","article-title":"Attomol-level ATP bioluminometer for detecting single bacterium","volume":"32","author":"Okanojo","year":"2017","journal-title":"Luminescence"},{"issue":"1\u20132","key":"10.1016\/j.mito.2019.11.001_b0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymgme.2006.05.015","article-title":"Lactic acidemia and mitochondrial disease","volume":"89","author":"Robinson","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2019.11.001_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127066","article-title":"L-Arginine affects aerobic capacity and muscle metabolism in MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes) syndrome","volume":"10","author":"Rodan","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.mito.2019.11.001_b0060","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","article-title":"FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies; a diagnostic study","volume":"10","author":"Suomalainen","year":"2011","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.mito.2019.11.001_b0065","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1212\/WNL.0000000000000169","article-title":"Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers","volume":"82","author":"Weiduschat","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.mito.2019.11.001_b0070","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ana.24506","article-title":"Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders","volume":"78","author":"Yatsuga","year":"2015","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.mito.2019.11.001_b0075","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","article-title":"MELAS: a nationwide prospective cohort study of 96 patients in Japan","volume":"1820","author":"Yatsuga","year":"2012","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724919302168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724919302168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:25:00Z","timestamp":1761589500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567724919302168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":15,"alternative-id":["S1567724919302168"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2019.11.001","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid ATP as a potential biomarker in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS)","name":"articletitle","label":"Article Title"},{"value":"Mitochondrion","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mito.2019.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and Mitochondria Research Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}